Nighttime Sleep-Aid tablets recalled due to carton labeling error
CVS Pharmacy is recalling Nighttime Sleep-Aid tablets because the carton incorrectly identifies the active ingredient as doxylamine succinate HCl instead of doxylamine succinate. Approximately 257,064 cartons were distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class III recalls are typically score 1-2 per the rubric. This is a labeling error on the product carton incorrectly identifying the chemical form of the active ingredient, classified as a minor labeling error corresponding to score 2 (Moderate).
Plain-English summary
CVS Pharmacy is recalling Nighttime Sleep-Aid (doxylamine succinate) tablets, 25 mg, in 48-count blisters, due to a labeling error on the product carton. The carton incorrectly identifies the active ingredient as doxylamine succinate HCl when the product actually contains doxylamine succinate.
The recalled product was distributed nationwide through a single retailer that may have further distributed it to other locations. Approximately 257,064 cartons were affected. The products were manufactured by LNK International, Inc., with 16 affected lot codes with expiration dates from August 2023 through April 2025.
Consumers who have purchased affected lots should check the lot code and expiration date information against the FDA's recall list. Those with questions may contact their pharmacist or healthcare provider.
The recalled product
- Product
- Nighttime Sleep-Aid (doxylamine succinate HCl) tablets, 25 mg, 48-count blisters per carton, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, UPC 0 50428 34873 4.
- Manufacturer
- LNK International, Inc.
- Hazard
- mis-labeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- P121512
- exp. date 08/2023
- P122015
- exp. date 09/2023
- P122712
- exp. date 11/2023
- P123090
- exp. date 12/2023
- P123170
- P124325
- exp. date 03/2024
- P124664
- P125165
- exp. date 05/2024
- P125576
- exp. date 06/2024
- P125577
- P127089
- exp. date 10/2024
- P127090
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27